[go: up one dir, main page]

GEP20053540B - Matrix Tablet for Sustained Release of Trimetazidine after Oral Administration - Google Patents

Matrix Tablet for Sustained Release of Trimetazidine after Oral Administration

Info

Publication number
GEP20053540B
GEP20053540B GE4838A GEAP2000004838A GEP20053540B GE P20053540 B GEP20053540 B GE P20053540B GE 4838 A GE4838 A GE 4838A GE AP2000004838 A GEAP2000004838 A GE AP2000004838A GE P20053540 B GEP20053540 B GE P20053540B
Authority
GE
Georgia
Prior art keywords
matrix tablet
trimetazidine
oral administration
sustained release
stenocardia
Prior art date
Application number
GE4838A
Inventor
De Barochez Bruno Huet
Claude Dauphant
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20053540(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of GEP20053540B publication Critical patent/GEP20053540B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Technical Result Stabilization of blood circulation. 2. Essence A matrix tablet additionally comprising polymer of cellulose derivatives to control prolonged release, method for production and use thereof for preventive treatment of stenocardia, chorioretinal attacks and vertigo of circulatory origin. 3. Field of Application Medicine.
GE4838A 1999-12-17 2000-12-15 Matrix Tablet for Sustained Release of Trimetazidine after Oral Administration GEP20053540B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915960A FR2802424B1 (en) 1999-12-17 1999-12-17 MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION

Publications (1)

Publication Number Publication Date
GEP20053540B true GEP20053540B (en) 2005-06-10

Family

ID=9553398

Family Applications (1)

Application Number Title Priority Date Filing Date
GE4838A GEP20053540B (en) 1999-12-17 2000-12-15 Matrix Tablet for Sustained Release of Trimetazidine after Oral Administration

Country Status (33)

Country Link
EP (1) EP1108424B2 (en)
JP (2) JP2001172181A (en)
KR (1) KR100456933B1 (en)
CN (1) CN1166408C (en)
AR (1) AR026968A1 (en)
AT (1) ATE296622T1 (en)
AU (1) AU780011B2 (en)
BG (1) BG65773B1 (en)
BR (1) BR0005915A (en)
CY (1) CY2347B1 (en)
CZ (1) CZ299461B6 (en)
DE (1) DE60020501T3 (en)
DK (1) DK1108424T4 (en)
EA (2) EA008223B1 (en)
ES (2) ES2176106B1 (en)
FR (1) FR2802424B1 (en)
GE (1) GEP20053540B (en)
GR (1) GR1003658B (en)
HK (1) HK1036937A1 (en)
HU (1) HU226956B1 (en)
IE (1) IE20001017A1 (en)
IT (1) IT1317075B1 (en)
LU (1) LU90700B1 (en)
MX (1) MXPA00012462A (en)
NZ (1) NZ508912A (en)
OA (1) OA12121A (en)
PL (1) PL206994B1 (en)
PT (2) PT1108424E (en)
SI (1) SI1108424T2 (en)
SK (1) SK286752B6 (en)
UA (1) UA80087C2 (en)
WO (1) WO2001043747A1 (en)
ZA (1) ZA200007548B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1195160E (en) * 2000-10-05 2009-12-07 Usv Ltd Sustained release trimetazidine pharmaceutical compositions and a method of their preparation
WO2005011682A1 (en) * 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. Sustained release tablet for oral use
SG126792A1 (en) * 2005-04-27 2006-11-29 Servier Lab Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
CZ300307B6 (en) * 2006-01-04 2009-04-15 Zentiva, A. S. Modified release tablet containing trimetazidine or pharmacologically acceptable salts thereof
EA009776B1 (en) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Method for preparing tablets of dihydrochloride trimethazine and composition thereof
EA009810B1 (en) * 2006-12-26 2008-04-28 Закрытое Акционерное Общество "Канонфарма Продакшн" Matrix for manufacturing tableted dosage form and method of treatment
WO2009034541A2 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
EP2389167A2 (en) 2009-01-20 2011-11-30 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
ES2567722T3 (en) * 2009-01-30 2016-04-26 Lupin Limited Trimetazidine pharmaceutical compositions
TR201001902A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
RU2445958C2 (en) * 2010-04-20 2012-03-27 Общество с ограниченной ответственностью "Озон" (ООО "Озон") Matrix tablet with trimetazidine prolonged-release base and method for preparing it
EP2394644B1 (en) 2010-05-04 2014-07-09 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Trimetazidine Formulation With Different Release Profiles
EP2386302A1 (en) 2010-05-11 2011-11-16 Ranbaxy Laboratories Limited A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
EP2491930A1 (en) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
FR2978916B1 (en) * 2011-08-10 2013-07-26 Servier Lab SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN
FR2986431B1 (en) * 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS
CN102824644B (en) * 2012-09-13 2013-12-25 浙江诚意药业有限公司 High-stability sustained-release tablet prepared by using hydroxy propyl cellulose
KR20160118733A (en) 2015-04-03 2016-10-12 이인현 Hose guide apparatus for hose winder and hose winder
CN109316455B (en) * 2017-07-31 2021-05-25 北京福元医药股份有限公司 Trimetazidine hydrochloride sustained release tablet
CN109908096A (en) * 2017-12-12 2019-06-21 武汉武药科技有限公司 A kind of trimetazidine hydrochloride sustained-release tablets and preparation method thereof
WO2024218267A2 (en) * 2023-04-20 2024-10-24 Les Laboratoires Servier Novel trimetazidine solid phases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
FR2490963B1 (en) * 1980-09-30 1986-04-18 Science Union & Cie NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE
KR850006132A (en) * 1984-02-29 1985-10-02 진 크라메르, 한스 루돌프 하우스 Bromocriptine Composition
JPS61293931A (en) * 1985-06-24 1986-12-24 Teijin Ltd Slow-releasing pharmaceutical composition
JPH0625055B2 (en) * 1985-03-18 1994-04-06 日本ケミフア株式会社 Persistent tablets
EP0207638B1 (en) * 1985-06-04 1990-12-19 Teijin Limited Sustained-release pharmaceutical preparation
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
SE8601624D0 (en) * 1986-04-11 1986-04-11 Haessle Ab NEW PHARMACEUTICAL PREPARATIONS
FR2677886B1 (en) * 1991-06-18 1995-03-31 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
FR2681324B1 (en) * 1991-09-18 1993-10-29 Adir Cie NOVEL TRIMETAZIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR940021051A (en) * 1993-03-03 1994-10-17 손정삼 3-step drug release sustained tablet
RU2082400C1 (en) * 1993-12-16 1997-06-27 Акционерное общество - Фармацевтическая фирма "Ник-Фарм" Method of nitroglycerol prolonged action preparing
FR2717687B1 (en) * 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.

Also Published As

Publication number Publication date
CZ299461B6 (en) 2008-08-06
MXPA00012462A (en) 2002-06-04
KR20010062478A (en) 2001-07-07
IE20001017A1 (en) 2002-04-03
AU7228500A (en) 2001-06-21
SK286752B6 (en) 2009-04-06
HK1036937A1 (en) 2002-01-25
PT102542A (en) 2001-06-29
EA008223B1 (en) 2007-04-27
DE60020501D1 (en) 2005-07-07
EA200501901A1 (en) 2006-06-30
ZA200007548B (en) 2001-06-19
PL206994B1 (en) 2010-10-29
WO2001043747A8 (en) 2001-09-07
WO2001043747A1 (en) 2001-06-21
KR100456933B1 (en) 2004-11-10
LU90700B1 (en) 2007-12-03
BR0005915A (en) 2001-10-02
HU226956B1 (en) 2010-03-29
CZ20022082A3 (en) 2002-09-11
JP2007314578A (en) 2007-12-06
AU780011B2 (en) 2005-02-24
ES2176106B1 (en) 2004-01-16
ITRM20000667A1 (en) 2002-06-14
SI1108424T1 (en) 2005-10-31
FR2802424B1 (en) 2002-02-15
ATE296622T1 (en) 2005-06-15
ITRM20000667A0 (en) 2000-12-14
EA200001201A3 (en) 2001-10-22
SI1108424T2 (en) 2014-02-28
BG65773B1 (en) 2009-11-30
CY2347B1 (en) 2004-06-04
DK1108424T3 (en) 2005-10-03
ES2176106A1 (en) 2002-11-16
DK1108424T4 (en) 2013-12-16
ES2240033T3 (en) 2005-10-16
EP1108424A1 (en) 2001-06-20
JP2001172181A (en) 2001-06-26
AR026968A1 (en) 2003-03-05
ES2240033T5 (en) 2014-01-16
FR2802424A1 (en) 2001-06-22
GR1003658B (en) 2001-09-05
HUP0004966A3 (en) 2008-04-28
EA200001201A2 (en) 2001-08-27
HUP0004966A2 (en) 2002-06-29
DE60020501T2 (en) 2006-04-27
DE60020501T3 (en) 2014-03-20
PL344564A1 (en) 2001-06-18
EP1108424B1 (en) 2005-06-01
OA12121A (en) 2003-10-20
CN1302663A (en) 2001-07-11
EP1108424B2 (en) 2013-09-04
BG106927A (en) 2003-05-30
HU0004966D0 (en) 2001-02-28
SK8632002A3 (en) 2002-10-08
CN1166408C (en) 2004-09-15
IT1317075B1 (en) 2003-05-26
PT1108424E (en) 2005-08-31
NZ508912A (en) 2002-04-26
UA80087C2 (en) 2007-08-27

Similar Documents

Publication Publication Date Title
GEP20053540B (en) Matrix Tablet for Sustained Release of Trimetazidine after Oral Administration
BR0109336A (en) A medicament for the prevention, amelioration and / or treatment of a diabetic complication, a suitable or usable medicinal drug thereof, a method for preventing, ameliorating and / or treating a diabetic complication, and neuropathy, and uses of a sugar reducing agent. in postprandial blood and at least one agent selected from an antihypertensive agent, a vasodilating agent and an antihyperlipidemic agent
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
HUP0001382A2 (en) Extended release formulations of erythromycin derivatives
YU19501A (en) Orally administrated controlled drug delivery system providing temporal and spatial control
KR20040037026A (en) Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
NZ527532A (en) Pharmaceutical formulation comprising bicalutamide
DE602004026701D1 (en) IMPLANTABLE MEDICINE PRODUCT FOR SELECTIVE MODULATION OF THE DISTRIBUTION OF MEDICINES IN SITU
AU2740595A (en) Transdermal drug delivery system
MXPA03006364A (en) Treatment of sleep disturbances.
CA2382387A1 (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
AU6050600A (en) Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidaseenzyme for the manufacture of medicament for the treatment of glycolipid storag e diseases
IS3644A7 (en) Method of preparing a pharmaceutical composition in the form of pellets for the treatment of intestinal inflammation
KR20080028361A (en) Quinine-containing controlled-release formulations
ATE198152T1 (en) ORAL MEDICINAL PREPARATION WITH DELAYED RELEASE OF ACTIVE INGREDIENTS
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
GEP20022763B (en) 2-(3,5-Bis-Trifluoromethyl-Phenyl)-N-Methyl-N-(6-Morpholin-4-Yl-4-O-Tolyl-Pyridin-3-Yl)-Isobutyramide, Method for its Production and Medicament Containing the Same for Treatment of the Diseases Caused by NK-1 Receptor
PT1196185E (en) NEW USE OF HYPO-OSMOTIC SALT SOLUTIONS AND MEDICINAL PRODUCTS BASED ON SUCH SOLUTIONS
FI89238B (en) FRAME STEERING TABLE FOR COMPRESSION TABLETTER
EP4226917A1 (en) Ibuprofen controlled-release tablet and preparation method thereof
GEP20053580B (en) Insoluble in Gastric Juice Microgranules, Method for its Production and Pharmaceutical Composition
BR9912533A (en) Pharmaceutical composition having improved taste
DE69420053D1 (en) NEUROPROTECTIVE CHROMAN CONNECTIONS
NZ515173A (en) Treatment of hypersensitivity reaction disorders
CN104146979A (en) Pramipexole dihydrochloride sustained release tablet and preparation method thereof